Učitavanje...
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome
Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...
Spremljeno u:
Glavni autori: | , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BMC
2022-04-01
|
Serija: | Thrombosis Journal |
Teme: | |
Online pristup: | https://doi.org/10.1186/s12959-022-00380-4 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|